49-1026

antibody from Invitrogen Antibodies

Targeting: NR3C1 GR, GRL

Western blot

ELISA

Immunoprecipitation

Immunohistochemistry

Antibody data

Submit

Validation data

NR3C1 protein structure - 49-1026 shown in red.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: COS-7 cells transiently overexpressing human GR were labeled with the monoclonal anti-hGR antibody followed by biotinylated second antibody and peroxidase-labeled avidin. The monoclonal antibody directed against GR (clone: m2F8) is used at 2.5 µg8260 mL.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescence analysis of Glucocorticoid Receptor (NR3C1) was performed using MDA-MB-231 cells (serum-starved) and MDA-MB-231 cells serum-starved for 24 hours, followed by 1 µM Dexamethasone treatment for 2 hours. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 2% BSA for 45 minutes at room temperature. The cells were labeled with Glucocorticoid Receptor Monoclonal Antibody (Product # 49-1026) at 5 µg/mL in 0.1% BSA, incubated at 4 degree celsius overnight and then labeled with Donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (Product # A32766), (1:2000), for 45 minutes at room temperature (Panel a: Green) in MDA-MB-231 treated cells. Nuclei (Panel b:Blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI (Product # P36962). F-actin (Panel c: Red) was stained with Rhodamine Phalloidin (Product # R415, 1:300). Panel d represents the merged image showing nuclear localization of NR3C1 protein in MDA-MB-231 treated cells. Panel e represents the merged image of MDA-MB-231 untreated cells, that shows cytoplasmic localization of NR3C1 protein. Panel f represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: ChIP assays were performed using HeLa cells, the anti-hGR monoclonal antibody (Product # 49-1026, clone: m2F8), and optimized PCR primer sets for qPCR. The cells were treated either with ethanol (EtOH) or triamcinolone acetonide (TA) for 4 hours prior to cell harvesting. Each ChIP assay used sheared chromatin from 3 million cells and 5 µg of the anti-hGR antibody. Recovery (%: ChIP⁄input; red bars) and occupancy (x fold: +ve⁄-ve; yellow bars)of human metallothionein promoter (hMTIIA) by GR, respectively, are shown. The recovery of human myoglobin exon 2 (hmyo ex2) by GR (%: ChIP⁄input; blue bars) was carried out as a negative control. Occupancy of the human metallothionein IIA promoter by GR is evident based on fluorescent qPCR analysis of immunoprecipitated DNA. Controls for IP and PCR specificity include primers for human myoglobin exon 2 (blue, negative control) and ethanol-treated cells.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: ChIP assays were performed using HeLa cells, the anti-hGR monoclonal antibody (Product # 49-1026, clone: m2F8), and optimized PCR primer sets for qPCR. The cells were treated either with ethanol (EtOH) or triamcinolone acetonide (TA) for 4 hours prior to cell harvesting. Each ChIP assay used sheared chromatin from 3 million cells and 5 µg of the anti-hGR antibody. Recovery (%: ChIP⁄input; red bars) and occupancy (x fold: +ve⁄-ve; yellow bars)of human metallothionein promoter (hMTIIA) by GR, respectively, are shown. The recovery of human myoglobin exon 2 (hmyo ex2) by GR (%: ChIP⁄input; blue bars) was carried out as a negative control. Occupancy of the human metallothionein IIA promoter by GR is evident based on fluorescent qPCR analysis of immunoprecipitated DNA. Controls for IP and PCR specificity include primers for human myoglobin exon 2 (blue, negative control) and ethanol-treated cells.